Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

PI3K/Akt pathway restricts epithelial adhesion of Dr + Escherichia coli by down-regulating the expression of decay accelerating factor.

Banadakoppa M, Goluszko P, Liebenthal D, Nowicki BJ, Nowicki S, Yallampalli C.

Exp Biol Med (Maywood). 2014 May;239(5):581-94. doi: 10.1177/1535370214522183. Epub 2014 Mar 5.

2.

Nitric oxide induces segregation of decay accelerating factor (DAF or CD55) from the membrane lipid-rafts and its internalization in human endometrial cells.

Banadakoppa M, Goluszko P, Liebenthal D, Yallampalli C.

Cell Biol Int. 2012 Oct 1;36(10):901-7. doi: 10.1042/CBI20110586.

3.

Group B streptococcus exploits lipid rafts and phosphoinositide 3-kinase/Akt signaling pathway to invade human endometrial cells.

Goluszko P, Popov V, Wen J, Jones A, Yallampalli C.

Am J Obstet Gynecol. 2008 Nov;199(5):548.e1-9. doi: 10.1016/j.ajog.2008.03.051. Epub 2008 May 19.

PMID:
18486087
4.

Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells.

Goluszko P, Nowicki B.

Infect Immun. 2005 Dec;73(12):7791-6. Review. No abstract available.

5.

Dra/AfaE adhesin of uropathogenic Dr/Afa+ Escherichia coli mediates mortality in pregnant rats.

Wroblewska-Seniuk K, Selvarangan R, Hart A, Pladzyk R, Goluszko P, Jafari A, du Merle L, Nowicki S, Yallampalli C, Le Bouguénec C, Nowicki B.

Infect Immun. 2005 Nov;73(11):7597-601.

6.

Hydrophilic domain II of Escherichia coli Dr fimbriae facilitates cell invasion.

Das M, Hart-Van Tassell A, Urvil PT, Lea S, Pettigrew D, Anderson KL, Samet A, Kur J, Matthews S, Nowicki S, Popov V, Goluszko P, Nowicki BJ.

Infect Immun. 2005 Sep;73(9):6119-26.

7.
8.

Interaction of Dr adhesin with collagen type IV is a critical step in Escherichia coli renal persistence.

Selvarangan R, Goluszko P, Singhal J, Carnoy C, Moseley S, Hudson B, Nowicki S, Nowicki B.

Infect Immun. 2004 Aug;72(8):4827-35.

9.

Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55.

Fang L, Nowicki BJ, Urvil P, Goluszko P, Nowicki S, Young SL, Yallampalli C.

Infect Immun. 2004 May;72(5):2907-14.

10.

Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation.

Hasan RJ, Pawelczyk E, Urvil PT, Venkatarajan MS, Goluszko P, Kur J, Selvarangan R, Nowicki S, Braun WA, Nowicki BJ.

Infect Immun. 2002 Aug;70(8):4485-93.

11.

Dr operon-associated invasiveness of Escherichia coli from pregnant patients with pyelonephritis.

Goluszko P, Niesel D, Nowicki B, Selvarangan R, Nowicki S, Hart A, Pawelczyk E, Das M, Urvil P, Hasan R.

Infect Immun. 2001 Jul;69(7):4678-80.

12.

Rapid receptor-clustering assay to detect uropathogenic and diarrheal Escherichia coli isolates bearing adhesins of the Dr family.

Goluszko P, Selvarangan R, Nowicki BJ, Nowicki S, Hart A, Pawelczyk E, Nguyen K.

J Clin Microbiol. 2001 Jun;39(6):2317-20.

13.

Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin.

Hart A, Nowicki BJ, Reisner B, Pawelczyk E, Goluszko P, Urvil P, Anderson G, Nowicki S.

J Infect Dis. 2001 May 15;183(10):1526-9. Epub 2001 Apr 6.

PMID:
11319690
14.

Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli.

Selvarangan R, Goluszko P, Popov V, Singhal J, Pham T, Lublin DM, Nowicki S, Nowicki B.

Infect Immun. 2000 Mar;68(3):1391-9.

15.
17.

Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line.

Goluszko P, Popov V, Selvarangan R, Nowicki S, Pham T, Nowicki BJ.

J Infect Dis. 1997 Jul;176(1):158-67.

PMID:
9207362
18.

Pelvic inflammatory disease isolates of Neisseria gonorrhoeae are distinguished by C1q-dependent virulence for newborn rats and by the sac-4 region.

Nowicki S, Ram P, Pham T, Goluszko P, Morse S, Anderson GD, Nowicki B.

Infect Immun. 1997 Jun;65(6):2094-9.

19.

Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.

Goluszko P, Moseley SL, Truong LD, Kaul A, Williford JR, Selvarangan R, Nowicki S, Nowicki B.

J Clin Invest. 1997 Apr 1;99(7):1662-72.

20.

Rapid cyclic changes in density and accessibility of endometrial ligands for Escherichia coli Dr fimbriae.

Kaul AK, Kumar D, Nagamani M, Goluszko P, Nowicki S, Nowicki BJ.

Infect Immun. 1996 Feb;64(2):611-5.

21.

Association of colony variation in Serratia marcescens with the differential expression of protease and type 1 fimbriae.

Goluszko P, Nowicki B, Goluszko E, Nowicki S, Kaul A, Pham T.

FEMS Microbiol Lett. 1995 Nov 1;133(1-2):41-5.

PMID:
8566711
22.

Dr fimbriae coding region associated hemolytic activity of Escherichia coli.

Goluszko P, Nowicki S, Kaul AK, Pham T, Nowicki BJ.

FEMS Microbiol Lett. 1995 Jul 15;130(1):13-7.

PMID:
7557290
23.

dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor.

Pham T, Kaul A, Hart A, Goluszko P, Moulds J, Nowicki S, Lublin DM, Nowicki BJ.

Infect Immun. 1995 May;63(5):1663-8.

24.

Decay-accelerating factor is expressed in the human endometrium and may serve as the attachment ligand for Dr pili of Escherichia coli.

Kaul A, Nowicki BJ, Martens MG, Goluszko P, Hart A, Nagamani M, Kumar D, Pham TQ, Nowicki S.

Am J Reprod Immunol. 1994 Oct;32(3):194-9.

PMID:
7533500
25.

Extracellular haemolytic activity of Serratia marcescens.

Goluszko P, Nowacki MR.

FEMS Microbiol Lett. 1989 Oct 1;52(1-2):207-11.

PMID:
2689279
26.

[Hemolytic properties of Acinetobacter calcoaceticus strains].

Gołuszko P, Gospodarek E.

Med Dosw Mikrobiol. 1988;40(4):219-25. Polish. No abstract available.

PMID:
3246922
28.

Haemolytic activity of Morganella morganii strains.

Gołuszko P, Gospodarek E, Bugalski R.

Acta Microbiol Pol. 1988;37(1):65-71.

PMID:
2462333
29.

[Characteristics of Acinetobacter strains isolated from a hospital environment. II. Drug resistance of Acinetobacter strains isolated from a hospital environment].

Bugalski R, Gospodarek E, Gołuszko P.

Med Dosw Mikrobiol. 1987;39(2):118-23. Polish. No abstract available.

PMID:
3657328
30.

[Characteristics of Acinetobacter strains isolated from a hospital environment. I. Presence of Acinetobacter in diagnostic specimens].

Bugalski R, Gospodarek E, Gołuszko P.

Med Dosw Mikrobiol. 1987;39(2):111-7. Polish. No abstract available.

PMID:
3657327
31.

[Drug resistance of Proteus vulgaris, Proteus morganii and Providencia rettgeri isolated from diagnostic specimens].

Gołuszko P, Gospodarek E, Bugalski R.

Przegl Epidemiol. 1987;41(3):319-23. Polish. No abstract available.

PMID:
3324173
32.

[Bacteriocin types of Proteus isolated from diagnostic specimens].

Gołuszko P, Grabowska A.

Przegl Epidemiol. 1985;39(3-4):406-11. Polish. No abstract available.

PMID:
3913990
33.

[Characteristics of gentamicin-resistant strains of Staphylococcus aureus isolated from diagnostic specimens].

Gołuszko P, Grabowska A, Gospodarek E, Bugalski R, Marciniak M.

Przegl Epidemiol. 1984;38(4):435-40. Polish. No abstract available.

PMID:
6533685
34.

[Case of tubo-ovarian abscess due to Klebsiella pneumoniae].

Bugalski R, Burczyk J, Gołuszko P.

Wiad Lek. 1980 Sep 15;33(18):1505-7. Polish. No abstract available.

PMID:
7008363
35.

[Evaluation of the basic and expanded panels of phages in the identification of Staphylococcus aureus].

Samet A, Goluszko P.

Przegl Epidemiol. 1976;30(3):373-6. Polish. No abstract available.

PMID:
138151
36.

Sensitivity of Staphylococcus epidermidis to antibiotics and mercury salts in dependence on origin and attachment to Baird-Parker's subgroups.

Dryński S, Becla E, Gołuszko P, Krasuski A.

Contrib Microbiol Immunol. 1973;1:646-9. No abstract available.

PMID:
4805326

Supplemental Content

Loading ...
Support Center